Literature DB >> 1859551

Pharmaceutical representatives.

L Scarpinato.   

Abstract

Mesh：

Year:  1991        PMID： 1859551     DOI： 10.1007/bf02598322

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  7 in total

1.  Changes in drug prescribing patterns related to commercial company funding of continuing medical education.

Authors:  M A Bowman; D L Pearle
Journal:  J Contin Educ Health Prof       Date:  1988       Impact factor: 1.355

2.  The golden age of CME is yet to come.

Authors: 
Journal:  JAMA       Date:  1988-05-06       Impact factor: 56.272

3.  Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.

Authors:  N Lurie; E C Rich; D E Simpson; J Meyer; D L Schiedermayer; J L Goodman; W P McKinney
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

4.  We need ethical guidelines for promotion of prescription drugs to physicians.

Authors:  S D Solomon
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

5.  Industrial marketing and medical ethics.

Authors:  E M Bricker
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

6.  A matter of influence.

Authors:  S E Goldfinger
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

Review 7.  The past, present, and future of continuing medical education. Achievements and opportunities, computers and recertification.

Authors:  P R Manning; D W Petit
Journal:  JAMA       Date:  1987-12-25       Impact factor: 56.272
  7 in total
  1 in total

1.  The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities.

Authors:  G L Brotzman; D H Mark
Journal:  J Gen Intern Med       Date:  1993-03       Impact factor: 5.128
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.